Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8630759
Reference Type
Journal Article
Title
Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France
Author(s)
Quéromès, G; Destras, G; Bal, A; Regue, H; Burfin, G; Brun, S; Fanget, R; Morfin, F; Valette, M; Trouillet-Assant, S; Lina, B; Frobert, E; Josset, L
Year
2021
Journal
Emerging Microbes & Infections
EISSN:
2222-1751
Volume
10
Issue
1
Page Numbers
167-177
Language
English
PMID
33399033
DOI
10.1080/22221751.2021.1872351
Web of Science Id
WOS:000613523200001
URL
https://www.proquest.com/scholarly-journals/characterization-sars-cov-2-orf6-deletion/docview/2475396319/se-2?accountid=171501
Exit
Abstract
During routine molecular surveillance of SARS-CoV-2 performed at the National Reference Center of Respiratory Viruses (Lyon, France) (n = 229 sequences collected February-April 2020), two frameshifting deletions were detected in the open reading frame 6, at the same position (27267). While a 26-nucleotide deletion variant (D26) was only found in one nasopharyngeal sample in March 2020, the 34-nucleotide deletion (D34) was found within a single geriatric hospital unit in 5/9 patients and one health care worker in April 2020. Phylogeny analysis strongly suggested a nosocomial transmission of D34, with potential fecal transmission, as also identified in a stool sample. No difference in disease severity was observed between patients hospitalized in the geriatric unit infected with WT or D34. In vitro D26 and D34 characterization revealed comparable replication kinetics with the wild-type (WT), but differential host immune responses. While interferon-stimulated genes were similarly upregulated after infection with WT and ORF6 variants, the latter specifically induced overexpression of 9 genes coding for inflammatory cytokines in the NF-kB pathway, including CCL2/MCP1, PTX3, and TNFα, for which high plasma levels have been associated with severe COVID-19. Our findings emphasize the need to monitor the occurrence of ORF6 deletions and assess their impact on the host immune response.
Keywords
Cytokines; ORF6 protein, SARS-CoV-2; Viral Proteins; Index Medicus; SARS-CoV-2; nosocomial cluster; deletion; inflammation; genomic surveillance; Sequence Deletion; Frameshift Mutation; Hospitalization; Cytokines -- immunology; Phylogeny; France -- epidemiology; Immunity; Base Sequence; Aged, 80 and over; Genetic Variation; Cross Infection -- virology; Genome, Viral; Viral Proteins -- immunology; COVID-19 -- virology; Cross Infection -- immunology; COVID-19 -- immunology; COVID-19 -- epidemiology; Cross Infection -- epidemiology; SARS-CoV-2 -- genetics; Viral Proteins -- genetics
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity